Press Releases

December 1, 2014

One Lambda Announces the Availability of its New RUO NXType Kit, a Complete Solution for HLA Typing by NGS

CANOGA PARK, CA—One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of research and in vitro diagnostic products for the HLA transplant community, today launched its RUO NXType™ Kit, a research use only (RUO) solution for human leukocyte antigen (HLA) typing by next-generation sequencing (NGS). The NXType sequencing kits feature long-range primers and an improved chemistry on the Ion Torrent Personal Genome Machine (PGM) system, enabling full-range sequencing of HLA Class I & II genes in three days.

This solution means that One Lambda can now provide laboratories with everything they need for their NGS HLA typing needs. In addition to the PGM instrument, the NXType reagent workflow includes: a comprehensive kit containing HLA Primer Mixes, ancillary reagents and TypeStream™, One Lambda’s exclusive NGS Analysis Software. The NXType reagent workflow also includes a comprehensive customer support system that provides users with in-depth training and technical support to ensure a smooth transition to this new technology.

“One Lambda has successfully streamlined our NGS workflow with their new NXType Kit by greatly improving the efficiency on the PGM platform,” said Dr. Susan Hsu of the American Red Cross in Philadelphia. “The pooling of the library preparation and enhanced workflow has given the NXType Kit and the PGM platform a distinct advantage in the NGS HLA typing arena. One major advantage with our NXType assay is that one technologist in a laboratory can now fully sequence HLA Class I & II genes within three working days.”

The new NXType assay brings together a unique, three-day workflow that is suitable for many laboratory applications and can be customized to handle a range of sample sizes. The NXType reagent workflow uses a five-step process that enables the user to take a methodical, time-saving approach to high resolution HLA typing.

NXType assays are currently available in RUO format with future plans for CE and IVD marks. For more information on the NXType assay, visit

About One Lambda

One Lambda, Inc., part of Thermo Fisher Scientific, is the worldwide leader in HLA typing and antibody detection assays. One Lambda is known for its commitment to quality, service, and innovation. The company develops and distributes several lines of HLA typing and antibody detection tests utilizing serological, molecular, ELISA, Flow, and xMAP technologies. In addition, One Lambda also manufactures laboratory instrumentation and computer software that are used to simplify and automate testing procedures and final test evaluations. For more information, please visit

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our four premier brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit

Last Updated: 2016.05.24 (for trademark usage)